Blog | Think Bold, Think Scientific, Think Veristat

2 min read

On-Demand Webinar: Single-Arm Studies for Use as a Registrational Study in Oncology

1 min read

On-Demand Webinar: Natural History Study for Ultra-Rare Diseases

Were you able to join Veristat’s live webinar- “Strategies for Solving the Challenges of an Extraordinary Natural History Study – Navigating the Patient Experience When Pivoting to a Virtual Model Mid-Study”? 

3 min read

Joining HIPRA to Take Aim at the Continuing Challenges of COVID-19

UPDATE – Veristat study collaboration with HIPRA leads to EMA approval of BIMERVAX^® COVID-19 vaccine, the first bivalent recombinant protein vaccine to be authorized in the EU and the first human health vaccine to be designed and developed in Spain.

2 min read

A Paradigm Shift in Monitoring Clinical Trials

What we know as work has experienced a major transformation. This shift and the changes it precipitated have affected how we now conduct and perform monitoring of clinical trials.